Editor’s note: This is a developing news story. Please check back soon for updates.Alcon will acquire LumiThera, including its photobiomodulation device for early and intermediate dry age-related macular degeneration, according to a press release.The p…
Author: Healio ophthalmology
VIDEO: Clinical Trials at the Summit highlights pipeline of geographic atrophy therapies
LAS VEGAS — In this video, Tarek S. Hassan, MD, professor of ophthalmology at Oakland University William Beaumont Hospital, discusses interesting data presented at Clinical Trials at the Summit, particularly regarding geographic atrophy.“This is a terr…
Woman referred for asymmetric diffuse retinal hemorrhages
A 69-year-old woman was referred to the retina service for abnormal posterior segment findings.The patient’s medical history was notable for bilateral hearing loss and type 2 diabetes diagnosed 10 years ago. While her HbA1c peaked to 12.7% 2 years prio…
Regenerative approaches to endothelial disease: What’s on the horizon?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.While endothelial keratoplasty (EK) has taken off and…
Canabrava Ring offers advantages for iris expansion
Our guest columnist is Sérgio Felix Canabrava, MD, of Brazil, who pioneered the Canabrava IOL fixation technique. In this column, he explains the Canabrava Ring iris expander.Priya Narang, MS, and Amar Agarwal, MS, FRCS, FRCOphth OSN Complications Cons…
VIDEO: Tyrosine kinase inhibitors may help alleviate wet AMD treatment burden
LAS VEGAS — In this video, Victor H. Gonzalez, MD, discusses “exciting” presentations at Clinical Trials at the Summit on wet age-related macular degeneration treatments, specifically those on tyrosine kinase inhibitors.“Hopefully, in the not too dista…
VIDEO: Multiple pathways available to treat wet AMD
LAS VEGAS — In this video from Clinical Trials at the Summit, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses multiple pathways to treat wet age-related macular degeneration.“I think we need to start looking at our treatments fo…
Small-aperture IOL improves vision in eyes with previous refractive surgery
LOS ANGELES — In patients who previously underwent refractive surgery or corneal inlay implantation, the small-aperture IC-8 Apthera IOL demonstrated positive vision outcomes, Robert E. Ang, MD, told Healio.At the American Society of Cataract and Refra…
AI diagnostic superiority over physicians may be ’exaggerated’
When Microsoft AI announced one of its systems solved complex medical cases more accurately and cost-effectively than expert physicians, the company touted the results as a first step on the “path to medical superintelligence.”Health care leaders with …
Federal judge blocks mass layoffs at HHS
A federal judge this week granted a preliminary injunction to halt mass layoffs at HHS, saying the Trump administration was not authorized to make sweeping changes to an agency created by Congress.The decision, handed down by U.S. District Court Judge …
Q&A: An interview with the hosts of ‘This Podcast Will Kill You’
PHOENIX — The hosts of “This Podcast Will Kill You” encouraged attendees at this year’s Association for Professionals in Infection Control and Epidemiology meeting to become better science communicators.Erin Allmann Updyke, MD, PhD, MPH, an epidemiolog…
The French paradox: Lessons for American practice management
“There is nothing so useless as doing efficiently that which should not be done at all.”– Peter Drucker“There’s a way to do it better — find it.”– Thomas A. EdisonWe recently finished a small consulting project in a suburban Paris eye clinic. Opportuni…
MIGS choice based on clinical, nonclinical factors
Click here to read the Cover Story, ” Interventional glaucoma mindset goes beyond traditional management strategies. “Before we start a conversation about how to make a choice between the different options for MIGS, we need to acknowledge that there is…
Jerry A. Shields, MD, leader in ocular oncology, dies
Jerry A. Shields, MD, a world-renowned leader in ocular oncology, died June 22, according to a press release from Wills Eye Hospital.Born in Kentucky in 1937, Shields was emeritus director of the ocular oncology service at Wills Eye Hospital and profes…
Vision Expo East, West to become one event in 2026
The Vision Council and RX announced that Vision Expo East and Vision Expo West will transition into one annual conference, the first of which will take place March 11-14, 2026, in Orlando, rotating through major U.S. cities each year.The co-owners of t…
Early-stage trial of endothelin antagonist yields improvements in DR
LAS VEGAS — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time results of PER-001 intravitreal implant in diabetic retinopathy.PER-001 (Perfuse Therapeutics), an endothelin antag…
VIDEO: Analysis shows fewer patients may be needed for GA trials
SALT LAKE CITY — In this video, Christine Curcio, PhD, FARVO, discusses data from a pixel-based analysis of the progression of geographic atrophy.A power analysis of the new analytic technique, presented at the Association for Research in Vision and Op…
Interventional glaucoma therapy will continue to gain traction
Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The mean IOP of a U.S. patient is 15 mm Hg, and the standard deviation rounded up is 3 mm Hg. Classical teaching is that a patient…
Q&A: Women in Medicine Summit will offer attendees a ‘safe space’ to engage in dialogue
This year’s Women in Medicine Summit is being held in Chicago from Sept. 18 to Sept. 20.The summit offers mentorship and networking opportunities, education, workshops, presentations and toolkits while representing over 70 specialties.Healio spoke with…
Reduced treatment burden, good safety profile seen with bilateral gene therapy for wet AMD
LAS VEGAS — Ashkan M. Abbey, MD, presented 1-year fellow eye substudy results for ABBV-RGX-314, a subretinal gene therapy from Regenxbio for wet age-related macular degeneration.At Clinical Trials at the Summit, Abbey addressed concerns about using gen…